Is there any use for nontraditional or alternative therapies in patients with chronic liver disease?

被引:11
作者
Bass N.M. [1 ]
机构
[1] Division of Gastroenterology, UCSF Medical Center, Rm, Box 0538, San Francisco, 94143-0538, CA
关键词
Liver Disease; Chronic Liver Disease; Alternative Therapy; Chinese Herbal Medicine; Silymarin;
D O I
10.1007/s11894-999-0087-2
中图分类号
学科分类号
摘要
There has been a substantial increase in the use of so-called complementary and alternative therapies by patients with liver disease. Although many such modalities are available, herbal therapies are the most popular, and of these remedies, silymarin extracted from the milk thistle is most widely subscribed to as a remedy for liver diseases. Available evidence points to a potential, but unproven, benefit for this as well as other therapies based on free radical scavenger or antioxidant principles in treating patients with liver disease. These therapies deserve further investigation through experimental studies and well-controlled clinical trials. Benefits to patients from these therapies, especially to patients with established cirrhosis, are most likely to be modest and insignificant. Conversely, the hepatotoxic potential of some alternative treatments is well recognized. As practitioners educating and treating patients with liver disease, we are obliged to be informed about popular alternative therapies, understanding of our patients' need to be partners in their care, and open-minded to the possibility that some benefit may come from some therapies currently regarded as alternative. We need to be effective and tolerant in learning about which alternative treatments our patients are taking, so that we can monitor their effects if any and counsel appropriately against those that may cause harm.
引用
收藏
页码:50 / 56
页数:6
相关论文
共 126 条
[1]  
Carroll RJ(1998)When patients want "alternative" care ACP-ASIM Oberserver 18 1-1
[2]  
Eisenberg DM(1993)Unconventional medicine in the United States: prevalence, costs, and patterns of use N Engl J Med 328 246 252-246 252
[3]  
Kessler RC(1998)The prevalence of complementary/alternative medicine in cancer: a systematic review Cancer 83 777-782
[4]  
Foster C(1995)Who uses AIDS alternative therapies and what happens to them? Outcomes from the use of AIDS alternativ therapies among people infected with HIV: a synthesis of the medical literature [abstract] Ahsr Fhsr Annu Meet Abstr Book 12 82-83
[5]  
Ernst E(1997)Current trends in the integration and reimbursement of complementary and alternative medicine by managed care, insurance carriers, and hospital providers Am J Health Promotion 12 112-122
[6]  
Cassileth BR(1997)Advising patients who seek alternative medical therapies Ann Intern Med 127 61-69
[7]  
Ryan JG(1996)The U.S. botanical market: an overview Herbalgram 36 49-57
[8]  
Pelletier KR(1997)Defining and describing complementary and alternative medicine. CAM Research Methodology Conference, 1995 Alternative Ther Health Med 3 49-57
[9]  
Marie A(1998)Alternative medicine: the risks of untested and unregulated remedies [editorial] N Engl J Med 339 839-841
[10]  
Krasner M(1994)Nutritional supplementation in chronic liver disease: an analytical review Hepatology 19 518-533